Litcius/Paper detail

Tissue engineered endothelial keratoplasty in rabbit: tips and tricks

Emmanuel Crouzet, Zhiguo Hé, Olfa Ben Moussa, Marielle Mentek, Pierre‐François Isard, Benjamin Peyret, Fabien Forest, Philippe Gain, Noriko Koizumi, Naoki Okumura, Gilles Thuret

2021Acta Ophthalmologica19 citationsDOI

Abstract

PURPOSE: To report a detailed surgical procedure of tissue engineered endothelial keratoplasty (TEEK) in a rabbit model and its postoperative evaluation. METHODS: TEEKs were prepared 7 days before transplantation by seeding human or rabbit corneal endothelial cells on either femtosecond laser-cut ultrathin human stromal lamellae (fs-UTSL) or femtosecond laser-cut human anterior lens capsule (fs-HALC). Thirty transplantations were performed on aphakic eyes. Recombinant tissue plasminogen activator (rTPA) was used throughout the surgery. The native endothelium was removed by full-surface scraping and central descemetorhexis. The transplantation was performed as a human Descemet's membrane endothelial keratoplasty. Controls included Descemetorhexis only and transplantation of carrier alone. Postoperative follow-up was performed by slit lamp and optical coherence tomography, followed by histology. RESULTS: Controls remained oedematous. No fibrin occurred during surgery. All but three TEEKs adhered immediately. One/6 fs-UTSL and 9/16 fs-HALC cleared perfectly (p = 0.161). All failures could be explained by at least one of the following causes intraoperative bleeding, vitreous prolapsus, early partial detachment, postoperative irido corneal synechiea/angle closure. Presumed immune rejection was observed in three rabbits only after 4 weeks. Immunostaining with anti-human CD166 allowed to perfectly differentiate human cells from rabbit cells. In successful TEEK at 3 or 4 weeks, human cells formed a normal endothelium and started migrating outside the carrier. CONCLUSION: Though the transplantation of a TEEK in rabbits is a complex model with many causes of failure, established procedure including use of rTPA allows reliable preclinical study. In addition, we suggest that fs-HALC might be a potential carrier for TEEK.

Topics & Concepts

TransplantationMedicineOphthalmologyFibrinEndotheliumCorneal transplantationTrabecular meshworkStromal cellCorneal endotheliumPathologySurgeryCorneaIntraocular pressureImmunologyEndocrinologyCorneal surgery and disordersCorneal Surgery and TreatmentsIntraocular Surgery and Lenses